[ M2i Life Sciences raises $13M in funding ]

M2i Life Sciences has raised $13 million in funding.

Founded in 2013, M2i Life Sciences  is an expert in the design, formulation and production of complex molecules. It develops pheromones for crop protection, animal health and human health, producing agricultural chemical products in the Biocontrol sector, which address the issue of tackling increasing resistance and toxicity of insecticides and GMOs with a new generation of natural solutions.

The new financing will be used to enable biocontrol producer M2i to finance the approval process of its Biocontrol products, pursue its R&D investment strategy and accelerate its international development.

Funding  undisclosed
Founded  2013
Country  France
City  Saint-Cloud
Founder / CEO  Philippe Guerret
Deal Size  $13M
Investors  Idinvest Partners
Previous Investors  /